Allison Dinsmore protests the profits of drug companies. Activists targeted Trustee Charles Heimbold, the outgoing CEO of Bristol-Myers Squibb, on campus yesterday. (Mia Villarreal Frietze/The Daily Pennsylvanian)
Allison Dinsmore protests the profits of drug companies. Activists targeted Trustee Charles Heimbold, the outgoing CEO of Bristol-Myers Squibb, on campus yesterday. (Mia Villarreal Frietze/The Daily Pennsylvanian)